{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:40:44Z","timestamp":1762540844922,"version":"3.44.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.virol.2022.08.006","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T07:59:19Z","timestamp":1661241559000},"page":"63-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice"],"prefix":"10.1016","volume":"575","author":[{"given":"Pola","family":"Olczak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Ling","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Kirnbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul F.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Roden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2022.08.006_bib1","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2022.08.006_bib2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/ijc.33683","article-title":"Transcription of human papillomaviruses in nonmelanoma skin cancers of the immunosuppressed","volume":"149","author":"Arroyo Muhr","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virol.2022.08.006_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2022.08.006_bib4","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1093\/cid\/ciaa1897","article-title":"Immunogenicity and safety of the 9-valent human papillomavirus vaccine in solid organ transplant recipients and adults infected with human immunodeficiency virus (HIV)","volume":"73","author":"Boey","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2022.08.006_bib5","article-title":"Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: a multicenter, prospective cohort study","author":"Bouwes Bavinck","year":"2017","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.virol.2022.08.006_bib6","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/carcin\/15.8.1597","article-title":"Experimental reproduction of the papilloma-carcinoma complex of the alimentary canal in cattle","volume":"15","author":"Campo","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.virol.2022.08.006_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1189\/jlb.0407247","article-title":"Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice","volume":"83","author":"Daley","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.virol.2022.08.006_bib8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2010.08.003","article-title":"In vivo mechanisms of vaccine-induced protection against HPV infection","volume":"8","author":"Day","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2022.08.006_bib9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1128\/CVI.00139-12","article-title":"A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies","volume":"19","author":"Day","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.virol.2022.08.006_bib10","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1084\/jem.20170308","article-title":"The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to beta-papillomaviruses","volume":"215","author":"de Jong","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2022.08.006_bib11","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3389\/fmicb.2018.01222","article-title":"Epidermodysplasia verruciformis: inborn errors of immunity to human beta-papillomaviruses","volume":"9","author":"de Jong","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2022.08.006_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virol.2022.08.006_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/ajt.16358","article-title":"Mus musculus papillomavirus 1 is a key driver of skin cancer development upon immunosuppression","volume":"21","author":"Dorfer","year":"2021","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.virol.2022.08.006_bib14","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/S0140-6736(21)02178-4","article-title":"The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study","volume":"398","author":"Falcaro","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2022.08.006_bib15","doi-asserted-by":"crossref","first-page":"11585","DOI":"10.1128\/JVI.01577-07","article-title":"Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2","volume":"81","author":"Gambhira","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2022.08.006_bib16","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/path.4065","article-title":"Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer","volume":"228","author":"Geraets","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.virol.2022.08.006_bib17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3389\/fmicb.2018.00874","article-title":"Cutaneous papillomaviruses and non-melanoma skin cancer: causal agents or innocent bystanders?","volume":"9","author":"Hasche","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2022.08.006_bib18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1093\/jnci\/djp106","article-title":"Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines","volume":"101","author":"Jagu","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.virol.2022.08.006_bib19","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/JVI.03218-12","article-title":"Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine","volume":"87","author":"Jagu","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2022.08.006_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0190-9622(00)90154-3","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"42","author":"Jensen","year":"2000","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.virol.2022.08.006_bib21","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.1016\/j.vaccine.2017.07.086","article-title":"Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes","volume":"35","author":"Kalnin","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2022.08.006_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/jnci\/djab080","article-title":"Real-world effectiveness of human papillomavirus vaccination against cervical cancer","volume":"113","author":"Kjaer","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.virol.2022.08.006_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097232","article-title":"Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types","volume":"9","author":"Kwak","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2022.08.006_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2012.10830.x","article-title":"A systematic review of worldwide incidence of nonmelanoma skin cancer","volume":"166","author":"Lomas","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.virol.2022.08.006_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.seminoncol.2014.12.032","article-title":"Human papillomaviruses and non-melanoma skin cancer","volume":"42","author":"McLaughlin-Drubin","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.virol.2022.08.006_bib26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1155\/2007\/942650","article-title":"Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations","volume":"23","author":"Nindl","year":"2007","journal-title":"Dis. Markers"},{"key":"10.1016\/j.virol.2022.08.006_bib27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1073\/pnas.75.3.1537","article-title":"Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis","volume":"75","author":"Orth","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2022.08.006_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2003.12.027","article-title":"Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18","volume":"321","author":"Pastrana","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.virol.2022.08.006_bib29","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","article-title":"Global burden of cancers attributable to infections in 2012: a synthetic analysis","volume":"4","author":"Plummer","year":"2016","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.virol.2022.08.006_bib30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaad.2016.12.035","article-title":"Re-evaluation of epidermodysplasia verruciformis: reconciling more than 90 years of debate","volume":"76","author":"Przybyszewska","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.virol.2022.08.006_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/nrc.2018.13","article-title":"Opportunities and challenges for human papillomavirus vaccination in cancer","volume":"18","author":"Roden","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.virol.2022.08.006_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01003-18","article-title":"An emerging issue in oncogenic virology: the role of beta human papillomavirus types in the development of cutaneous squamous cell carcinoma","volume":"93","author":"Rollison","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2022.08.006_bib33","doi-asserted-by":"crossref","first-page":"10766","DOI":"10.1128\/JVI.74.22.10766-10777.2000","article-title":"Variation in the nucleotide sequence of cottontail rabbit papillomavirus a and b subtypes affects wart regression and malignant transformation and level of viral replication in domestic rabbits","volume":"74","author":"Salmon","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2022.08.006_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1084\/jem.65.2.219","article-title":"Immunization of rabbits to infectious papillomatosis","volume":"65","author":"Shope","year":"1937","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2022.08.006_bib35","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-019-1719-9","article-title":"Immunity to commensal papillomaviruses protects against skin cancer","volume":"575","author":"Strickley","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.virol.2022.08.006_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virusres.2016.11.013","article-title":"The biology of beta human papillomaviruses","volume":"231","author":"Tommasino","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2022.08.006_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002125","article-title":"E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice","volume":"7","author":"Viarisio","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2022.08.006_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006783","article-title":"Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice","volume":"14","author":"Viarisio","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2022.08.006_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003924","article-title":"Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model","volume":"10","author":"Vinzon","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2022.08.006_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002807","article-title":"HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage","volume":"8","author":"Wallace","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2022.08.006_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004687","article-title":"beta-HPV 5 and 8 E6 disrupt homology dependent double strand break repair by attenuating BRCA1 and BRCA2 expression and foci formation","volume":"11","author":"Wallace","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2022.08.006_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00572-18","article-title":"Roles of Fc domain and exudation in L2 antibody-mediated protection against human papillomavirus","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2022.08.006_bib43","first-page":"1","article-title":"Human papillomaviruses","volume":"64","year":"1995","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.virol.2022.08.006_bib44","doi-asserted-by":"crossref","first-page":"16086","DOI":"10.1074\/jbc.RA120.013045","article-title":"Expression of a TMC6-TMC8-CIB1 heterotrimeric complex in lymphocytes is regulated by each of the components","volume":"295","author":"Wu","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2022.08.006_bib45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"zur Hausen","year":"2002","journal-title":"Nat. Rev. Cancer"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682222001362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682222001362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:57:40Z","timestamp":1758589060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682222001362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":45,"alternative-id":["S0042682222001362"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2022.08.006","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with human alphapapillomavirus-derived L2 multimer protects against human betapapillomavirus challenge, including in epidermodysplasia verruciformis model mice","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2022.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}